Industry partnership opportunities
The 91亚色传媒 has teamed up with to provide 91亚色传媒 members fresh industry partnership opportunities each month. Below you'll find several requests for assistance from companies seeking certain expertise and technologies. Learn more about our partnership with Halo.
Bayer Pharma: Human stem cells from patients with genetically derived cardiomyopathy
Bayer Crop Science is seeking stem cells from patients with dilated cardiomyopathies (e.g. laminopathy or others). The genetic defect in those patients causing the disease should be known. They would also need certain clinical parameters of those patients. The cells are not intending to be used for clinical research and development. The deadline for this opportunity is May 31.
Private company: Unique methods to measure intestinal water and cotransporter regulation
This private company is looking to explore and optimize oral rehydration solutions through the utilization of validated intestinal models. The primary objectives involve evaluating the effects of different solution compositions on intestinal water absorption, solute absorption, and their potential to modulate the activity of co-transporters, particularly those responsible for the transport of sugars and amino acids. The deadline for this opportunity is April 30.
BASF: Biodegradable micro-encapsulation of active ingredients
BASF is seeking a biodegradable encapsulation material for hydrophobic active ingredients. Core-shell morphologies are of high interest, but relevant matrix capsules and other morphologies will be considered. The deadline for this opportunity is April 30.
Private company: Uncovering the “perfect” natural product from a specific bacteria
This private sponsor is seeking partners who can effectively identify natural project actives derived from a proprietary strain. These identified natural products should demonstrate activity against specific pathogens, while not falling under the categories of antibiotics, siderophores, volatile compounds, unstable polyenes or nonribosomally synthesized peptides. The deadline for this opportunity is April 30.
Enjoy reading 91亚色传媒 Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreFeatured jobs
from the
Get the latest from 91亚色传媒 Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Industry
Industry highlights or most popular articles
Black excellence in biotech: Shaping the future of an industry
This Black History Month, we highlight the impact of DEI initiatives, trailblazing scientists and industry leaders working to create a more inclusive and scientific community. Discover how you can be part of the movement.
Attend 91亚色传媒鈥檚 career and education fair
Attending the 91亚色传媒 career and education fair is a great way to explore new opportunities, make valuable connections and gain insights into potential career paths.
Benefits of attending a large scientific conference
Researchers have a lot of choices when it comes to conferences and symposia. A large conference like the 91亚色传媒 Annual Meeting offers myriad opportunities, such as poster sessions, top research talks, social events, workshops, vendor booths and more.
Biotech startup worms its way into therapeutics
Andrea Choe's company, Holoclara, has created an anti-inflammatory drug based on a molecule from worms.
How military forensic scientists use DNA to solve mysteries
Learn how two analysts at the Armed Forces DNA Identification Laboratory use molecular biology and genetics to identify the remains of fallen troops.
Careers in industry: A year in review
Careers columnist Inayah Entzminger looks back at 12 months of interviews, advice and lists of resources.